These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39144129)

  • 1. Immunogenicity of a novel inactivated canine adenovirus type 2 variant vaccine for dogs.
    Yang DK; Ahn S; Lee HJ; Kim M; Kim JT; Lee JY; Cho YS
    Clin Exp Vaccine Res; 2024 Jul; 13(3):253-258. PubMed ID: 39144129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs.
    Yang DK; Kim HH; Yoo JY; Ji M; Han BH; Oh S; Hyun BH
    Clin Exp Vaccine Res; 2020 Jan; 9(1):40-47. PubMed ID: 32095439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of an inactivated rabies vaccine for animals derived from the recombinant ERAGS strain.
    Yang DK; Kim HH; Park YR; Yoo JY; Park Y; An S; Hyun BH
    Clin Exp Vaccine Res; 2021 May; 10(2):141-147. PubMed ID: 34222126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of recombinant rabies virus (ERAGS) in mice and raccoon dogs.
    Yang DK; Kim HH; Choi SS; Kim JT; Lee KB; Lee SH; Cho IS
    Clin Exp Vaccine Res; 2016 Jul; 5(2):159-68. PubMed ID: 27489806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of an Inactivated Canine Adenovirus Type 1 Vaccine for Foxes.
    Fu Y; Sun J; Lian S; Deng X; Zhang L; Shao J; Yu H; Yan X; Zhu Y
    Front Vet Sci; 2022; 9():678671. PubMed ID: 35242832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Characteristics of Canine Adenovirus Type 2 Detected in Wild Raccoon Dogs (
    Kim YJ; Lee SY; Kim YS; Na EJ; Park JS; Oem JK
    Vet Sci; 2022 Oct; 9(11):. PubMed ID: 36356068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of recombinant adenoviruses expressing glycoprotein or nucleoprotein of rabies virus to Korean raccoon dogs.
    Choi J; Yang DK; Kim HH; Jo HY; Choi SS; Kim JT; Cho IS; Kim HW
    Clin Exp Vaccine Res; 2015 Jul; 4(2):189-94. PubMed ID: 26273578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biological characteristics of the canine adenovirus type 1 from fox and the transcriptome analysis of the infected MDCK cell.
    Zhu Y; Sun J; Yan M; Lian S; Hu B; Lv S; Li Y; Zhang Y; Yan X
    Cell Biol Int; 2021 May; 45(5):936-947. PubMed ID: 33382191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Booster effect of canine distemper, canine parvovirus infection and infectious canine hepatitis combination vaccine in domesticated adult dogs.
    Taguchi M; Namikawa K; Maruo T; Orito K; Lynch J; Tsuchiya R; Sahara H
    Microbiol Immunol; 2012 Aug; 56(8):579-82. PubMed ID: 22672137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine - A phase I randomized clinical trial.
    Cheng A; Hsieh SM; Pan SC; Li YH; Hsieh EF; Lee HC; Lin TW; Lai KL; Chen C; Shi-Chung Chang S; Chang SC
    J Microbiol Immunol Infect; 2019 Oct; 52(5):685-692. PubMed ID: 31255574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Serum Antibody Titers against Core Vaccine Antigens in Italian Dogs.
    Dall'Ara P; Lauzi S; Zambarbieri J; Servida F; Barbieri L; Rosenthal R; Turin L; Scarparo E; Filipe J
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
    Zhang Y; Ma X; Yan G; Wu Y; Chen Y; Zhou Z; Wan N; Su W; Liu FW; Dai MX; Yang M; Li C; Yu X; Zhang L; Wang Z; Zhou TC; You D; Wei J; Zhang Z;
    EClinicalMedicine; 2022 Dec; 54():101680. PubMed ID: 36188435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2.
    Müller T; Selhorst T; Burow J; Schameitat A; Vos A
    Dev Biol (Basel); 2006; 125():195-204. PubMed ID: 16878477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of equine herpesvirus-1 vaccine inactivated by both formaldehyde and binary ethylenimine in equine.
    Warda FF; Ahmed HES; Shafik NG; Mikhael CA; Abd-ElAziz HMG; Mohammed WA; Shosha EA
    Vet World; 2021 Jul; 14(7):1815-1821. PubMed ID: 34475703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: a phase I trial in Taiwan.
    Pan SC; Kung HC; Kao TM; Wu H; Dong SX; Hu MH; Chou AH; Chong P; Hsieh SM; Chang SC
    J Microbiol Immunol Infect; 2013 Dec; 46(6):448-55. PubMed ID: 23022464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial.
    Wu UI; Hsieh SM; Lee WS; Wang NC; Kung HC; Ou TY; Chen FL; Lin TY; Chen YC; Chang SC
    Vaccine; 2017 Jul; 35(33):4099-4104. PubMed ID: 28668573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs.
    McGettigan JP; David F; Figueiredo MD; Minke J; Mebatsion T; Schnell MJ
    Vaccine; 2014 Mar; 32(15):1716-9. PubMed ID: 24508037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets.
    Yeolekar LR; Guilfoyle K; Ganguly M; Tyagi P; Stittelaar KJ; van Amerongen G; Dhere RM; BerlandaScorza F; Mahmood K
    Vaccine; 2020 Sep; 38(40):6280-6290. PubMed ID: 32741671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.
    Omma A; Batirel A; Aydin M; Yilmaz Karadag F; Erden A; Kucuksahin O; Armagan B; Güven SC; Karakas O; Gokdemir S; Altunal LN; Buber AA; Gemcioglu E; Zengin O; Inan O; Sahiner ES; Korukluoglu G; Sezer Z; Ozdarendeli A; Kara A; Ates I
    Hum Vaccin Immunother; 2022 Nov; 18(6):2122503. PubMed ID: 36315843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
    Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
    BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.